InvestorNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Schedules Second-Quarter 2026 Results Webcast 

Lantern Pharma (NASDAQ: LTRN), an artificial intelligence-driven oncology company, announced it will host a webcast to discuss its second-quarter 2026 operating and financial results on Aug. 14, 2026, at 9 a.m. ET. President and CEO Panna Sharma, joined by members of the management team, will review results for the quarter ended June 30, 2026, and provide […]